Brought to you by 
ZymoGenetics nets $111.6mm with 10mm share IPO
11 Feb 2002
Executive Summary
ZymoGenetics (bioinformatics, protein-based drugs) netted $111.6mm through a 10mm common share initial public offering at $12 each. It had originally expected to price the shares at $16-18 each when it filed in September.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Bioinformatics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ZymoGenetics nets $111.6mm with 10mm share IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice